Psychedelics Weekly – Field Trip Health Closes Five Clinics, Legalization Bills Introduced in VT, and Ketamine Telehealth Uncertainty
Psychedelics Today17 Maalis 2023

Psychedelics Weekly – Field Trip Health Closes Five Clinics, Legalization Bills Introduced in VT, and Ketamine Telehealth Uncertainty

In this episode of Psychedelics Weekly, Joe and Kyle join up once again to discuss the news and articles they found the most interesting this week.

They start with the business news everyone is talking about: Field Trip Health & Wellness closing 5 of their clinics due to financial struggles (a deficit of $48.7 million since their inception and a net loss of $6.9 million reported for the last quarter), little confidence they'd be able to receive more funding, and the changing landscape of ketamine telehealth now that the Covid Public Health Emergency should finally come to an end in May. They also highlight an article dissecting the collapse of Synthesis Institute and the lessons to be learned, with both stories really showing just how new and unstable psychedelic business still is, and how the allure of first-mover advantage can be a dangerous gamble.

They also discuss four drug reform bills introduced in Vermont: two of which would decriminalize simple possession of all drugs, making a "personal use supply of drugs" a civil offense with a $50 fine; one removing penalties for using or selling psilocybin; and the last decriminalizing certain psychedelic plants and fungi.

And they look at a research study aiming to learn more about people's lives after they've been involved in a clinical trial, Time Magazine's article about psychedelics and couples therapy, and a study that found that while 64% of survey respondents said at-home ketamine helped their symptoms, 55% (and 58% of Millennials) said they used more than the recommended dose – either by accident or on purpose.

www.psychedelicstoday.com

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(774)

PT568 – The 3-Axis Framework: A New Model for Psychedelic Work, with Pierre Bouchard, LPC, LM

PT568 – The 3-Axis Framework: A New Model for Psychedelic Work, with Pierre Bouchard, LPC, LM

In this episode, Kyle interviews Pierre Bouchard, LPC, LM: therapist, minister, and former professional vinyl DJ specializing in psychedelic-assisted psychotherapy and ministry. Bouchard introduces h...

26 Marras 20241h 9min

PT567 – Sex and Psychedelics: Healing Through Altered States, with Bria Tavakoli, LPCC, MA, MS

PT567 – Sex and Psychedelics: Healing Through Altered States, with Bria Tavakoli, LPCC, MA, MS

In this episode, Joe interviews Bria Tavakoli, LPCC, MA, MS: a therapist specializing in relational and sex therapy, with a focus on helping clients integrate psychedelic experiences. She shares her p...

22 Marras 20241h 13min

PT566 – Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry, with Juan Pablo Cappello

PT566 – Standards, Ethics, and Integration: Rebuilding Trust in the Ketamine Industry, with Juan Pablo Cappello

In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello discusses the current challenges ...

19 Marras 20241h 33min

PT565 – From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis, with Geoff Bathje, Ph.D.

PT565 – From Individualism to Connection: How Psychedelics and Group Therapy Can Heal Our Collective Crisis, with Geoff Bathje, Ph.D.

In this episode, Kyle interviews Geoff Bathje, Ph.D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketami...

15 Marras 20241h 8min

PT564 – How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy, with Thomas Feegel

PT564 – How Safe is Ibogaine Therapy? The Delicate Balance of Risk and Efficacy, with Thomas Feegel

In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found t...

11 Marras 20241h 8min

PT563 – Why Psychedelic Research is Booming: Current Trends and Hurdles, with Floris Wolswijk

PT563 – Why Psychedelic Research is Booming: Current Trends and Hurdles, with Floris Wolswijk

In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, tri...

8 Marras 20241h 29min

PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy

PT562 – Ketamine-Assisted Therapy at Work? The Future of Employee Benefits, with Jessica Tracy

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assist...

5 Marras 202445min

PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller

PT561 – Psychedelics Lately – Massachusetts' Question 4 and Updates in Psychedelics and Chronic Pain, with Joe Moore & Kyle Buller

In this episode, Joe and Kyle finally meet up again for the first episode of Psychedelics Lately: the updated version of the much-missed Psychedelics Weekly, where they'll meet each month to talk abou...

1 Marras 202455min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
tiedekulma-podcast
rss-poliisin-mieli
utelias-mieli
rss-tiedetta-vai-tarinaa
university-of-eastern-finland
docemilia
sotataidon-ytimessa
filocast-filosofian-perusteet
menologeja-tutkimusmatka-vaihdevuosiin
rss-bios-podcast
rss-ranskaa-raakana
rss-duodecim-lehti
rss-duokkari-ekstra
rss-astetta-parempi-elama-podcast
rss-ilmasto-kriisissa
rss-ylistys-elaimille
rss-sosiopodi
rss-totuuden-liepeilla